Company News

Connect with us at BIO-Europe Spring 2021!

KLUS Pharma is Attending BIO-Europe Spring

March 5th, 2021

KLUS Pharma will attend BIO Europe-Spring Digital Event held on March 22-25, 2021.

KLUS Pharma is Attending BIO Partnering at JPM 

December 5th, 2020

KLUS Pharma will attend BIO Partnering at JPM Digital Event held on January 11-15, 2021. 

Looking for Partnerships to Combat COVID-19

June 1st, 2020

We are looking for partnerships to develop and distribute ACV200-17, a peptide drug to prevent COVID-19, in affected countries.

IND for KL-A289 is Approved in China

September 2nd, 2020

The IND for KL-A289, an anti-LAG-3 monoclonal antibody, was recently approved by the NMPA in China. 

KLUS Pharma to Present at BIO Digital

May 7th, 2020

KLUS Pharma will present an update for SKB264, a novel TROP2 ADC undergoing a Phase 1/2 clinical trial.

KLUS Pharma to Present at ASCO Annual Meeting

April 25th, 2020

KLUS Pharma will present clinical updates for our HER2 and TROP2 ADC programs at ASCO held on May 29-31, 2020.

©2021 by KLUS Pharma Inc.